Biogen Pharmachem Industries Profit & Loss Annual

BSE: 531752 | NSE: - | ISIN: INE703D01023 | Sector: Investment Services

1.23 0.00 (0.00%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	0.00	-	2.47	1.62
Total Revenue	0.00	0.00	2.47	1.62
Costof Revenue Total	0.00	0.00	2.02	1.48
Gross Profit	0.00	-	0.46	0.14
Selling/ General/ Admin Expenses Total	0.08	0.17	0.05	0.01
Depreciation/ Amortization	0.00	0.00	0.00	0.00
Other Operating Expenses Total	0.37	0.28	0.42	1.73
Total Operating Expense	0.45	0.46	2.49	3.23
Operating Income	-0.45	-0.46	-0.02	-1.60
Other Net	2.38	0.25	0.01	0.00
Net Income Before Taxes	1.93	0.46	-0.01	-1.60
Provisionfor Income Taxes	0.00	0.00	0.00	0.00
Net Income After Taxes	1.93	0.46	-0.01	-1.60
Net Income Before Extra Items	1.93	0.46	-0.01	-1.60
Net Income	1.93	0.46	-0.01	-1.60
Income Availableto Com Excl Extra Ord	1.93	0.46	-0.01	-1.60
Income Availableto Com Incl Extra Ord	1.93	0.46	-0.01	-1.60
Diluted Net Income	1.93	0.46	-0.01	-1.60
Diluted Weighted Average Shares	64.36	65.26	65.26	65.26
Diluted EPS Excluding Extra Ord Items	0.03	0.01	0.00	-0.02
Diluted Normalized EPS	0.03	0.01	0.00	-0.02
Interest Inc( Exp) Net- Non- Op Total	-	6.63	-	-